Procyon Corporation (PCYN)

OTCMKTS · Delayed Price · Currency is USD

0.201

0.00 (0.00%)

At close: Apr 23, 2026

11.67% (1Y)

Market Cap	1.65M
Revenue (ttm)	4.98M
Net Income (ttm)	-312.96K
Shares Out	8.19M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	200
Average Volume	7,256
Open	0.201
Previous Close	n/a
Day's Range	0.201 - 0.201
52-Week Range	0.000 - 0.280
Beta	67,084.84
RSI	52.77
Earnings Date	May 22, 2026

About Procyon

Procyon Corporation, together with its subsidiaries, manufactures and markets wound and skin care products primarily in the United States. It provides AMERIGEL, an advanced skin and wound care products, including hydrogel wound dressing, post op surgical kits, saline wound washes, and care and barrier lotions; HELIX3 Bioactive Collagen products, such as collagen powder, gel, and matrix; and calcium alginate dressing, foam dressing, amerx gauze dressing, hyrdocolloid dressing, as well as wound care kits, including calcium alginate, collagen matr... [Read more]

Industry Drug Manufacturers - Specialty & Generic

Sector Healthcare

Founded 1987

Employees 20

Stock Exchange OTCMKTS

Ticker Symbol PCYN

Full Company Profile

Financial Performance

In fiscal year 2024, Procyon's revenue was $4.98 million, an increase of 6.35% compared to the previous year's $4.69 million. Losses were -$312,962, 367.4% more than in 2023.

Financial Statements

News

There is no news available yet.